Published online Dec 24, 2019. doi: 10.5306/wjco.v10.i12.382
Peer-review started: June 4, 2019
First decision: August 2, 2019
Revised: September 9, 2019
Accepted: November 4, 2019
Article in press: November 4, 2019
Published online: December 24, 2019
Processing time: 202 Days and 10.8 Hours
Weight gain is a potential negative outcome of breast-cancer treatment, occurring in 50%-to-96% of breast cancer patients, although the amount of weight gain is inconsistently reported in the literature. Weight gain can influence quality of life (QOL) during survivorship and even cancer reoccurrence.
We were motivated to do this analysis to examine body mass index (BMI) trends among breast cancer survivors and the trends’ relationship to QOL indicators over seven years. Identifying trends and their relationships to QOL provides insight into cancer survivorship care and care-planning.
We conducted this analysis to assess BMI trends among breast cancer survivors and to investigate whether those trends were related to quality of life. We identified small positive upticks in BMI over time amongst our participants. Future research should continue to examine weight changes in this population.
Data for this analysis were collected during a study entitled the Breast Cancer and Lymphedema Project. Three-hundred seventy-eight women enrolled in the study at breast cancer diagnosis or just after surgery for breast cancer treatment. Participants were followed over seven years and the research team recorded their weight and 36-Item Short Form Survey (SF-36) scores at designated intervals during the study. BMI trends, change in BMI, and change in SF-36 subscales over seven years were calculated using a random-intercept repeated-measures regression. This method was selected because the data were longitudinal, and it allows for non-dependency between collection time points.
We found small upward trends in our participants’ BMI and those upward trends corresponded in a statistically significant way to several of the SF-36 subscales. Age and region were also significantly associated with BMI increase in the normal and obese BMI categories. Our results add to the existing body of work regarding BMI and breast cancer treatment. These results contribute to what is known and support efforts to continue research into breast cancer survivorship and the potentially chronic sequelae of treatment.
We place an emphasis on the need for continued support and surveillance through the years of survivorship. Our results support continued research in breast cancer survivorship research. Application of weight management and health promotion for survivorship care-planning in the clinical setting has potential to enhance optimal self-care and QOL in living with a chronic condition such as breast cancer survivorship.
We believe future research involving breast cancer survivors should go beyond weight loss and perhaps focus more on weight management, healthy lifestyle changes, and health promotion. Our results also bring awareness to the potential influences of rural and urban environments and how those environments may contribute to our understanding of the issues surrounding cancer survivorship.